92 related articles for article (PubMed ID: 1250555)
1. Management of endometriosis with oral medroxyprogesterone acetate.
Moghissi KS; Boyce CR
Obstet Gynecol; 1976 Mar; 47(3):265-7. PubMed ID: 1250555
[TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis.
Telimaa S; Puolakka J; Rönnberg L; Kauppila A
Gynecol Endocrinol; 1987 Mar; 1(1):13-23. PubMed ID: 2972167
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
Luciano AA; Turksoy RN; Carleo J
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):323-7. PubMed ID: 2970029
[TBL] [Abstract][Full Text] [Related]
4. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
Cedars MI; Lu JK; Meldrum DR; Judd HL
Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
[TBL] [Abstract][Full Text] [Related]
5. Treatment of endometriosis with leuprorelin acetate depot: a German multicentre study.
Gerhard I; Schindler AE; Bühler K; Winkler U; Meinen K; Mancarella D; Hoffmann G; Schüssler B; Kimmig R; Kranzfelder D
Clin Ther; 1992; 14 Suppl A():3-16. PubMed ID: 1535021
[TBL] [Abstract][Full Text] [Related]
6. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
Klaassen DJ; Rapp EF; Hirte WE
Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different treatment modalities of endometriosis in infertile women.
Hull ME; Moghissi KS; Magyar DF; Hayes MF
Fertil Steril; 1987 Jan; 47(1):40-4. PubMed ID: 2947817
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate.
Fåhraeus L; Sydsjö A; Wallentin L
Fertil Steril; 1986 Apr; 45(4):503-6. PubMed ID: 2937657
[TBL] [Abstract][Full Text] [Related]
9. Steroidal drugs in endometriosis.
Kauppila AJ; Telimaa S; Rönnberg L
Acta Obstet Gynecol Scand Suppl; 1989; 150():7-13. PubMed ID: 2533450
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic effects of medroxyprogesterone acetate in recurrent or advanced breast cancer].
Yoshida M; Murai H; Miura S
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):516-23. PubMed ID: 3159345
[TBL] [Abstract][Full Text] [Related]
11. [Oral high doses of medroxyprogesterone acetate (MPA) in the treatment of advanced phases of breast and endometrial cancer].
Bernardo-Strada MR; Imparato E; Aspesi G; Pavesi L; Robustelli Della Cuna G
Minerva Med; 1980 Nov; 71(44):3241-6. PubMed ID: 7454090
[TBL] [Abstract][Full Text] [Related]
12. Medroxyprogesterone acetate and lipid metabolic changes.
Teichmann AT; Wander HE; Cremer P; Wieland H; Kuhn W; Nagel GA; Seidel D
Arzneimittelforschung; 1987 May; 37(5):573-7. PubMed ID: 2956958
[TBL] [Abstract][Full Text] [Related]
13. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
[TBL] [Abstract][Full Text] [Related]
14. Oral versus im administration of high-dose medroxyprogesterone acetate in pretreated patients with advanced breast cancer.
Beex L; Burghouts J; van Turnhout J; Breed W; Hillen H; Holdrinet A; Boetius G; Hoogendoorn G; Doesburg W; Verhulst M
Cancer Treat Rep; 1987 Dec; 71(12):1151-6. PubMed ID: 3690524
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic management of endometriosis.
Saltiel E; Garabedian-Ruffalo SM
Clin Pharm; 1991 Jul; 10(7):518-31. PubMed ID: 1830521
[TBL] [Abstract][Full Text] [Related]
16. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
Nelson AL
J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
[TBL] [Abstract][Full Text] [Related]
17. Oral versus intramuscular high-dose medroxyprogesterone acetate (HD-MPA) in advanced breast cancer. A randomized study of the Belgian Society of Medical Oncology.
Paridaens R; Becquart D; Michel J; Vanderlinden B; Longueville J; Majois F; Beauduin M; Focan C; Wildiers J; Bernheim J
Anticancer Res; 1986; 6(5):1089-94. PubMed ID: 2948441
[TBL] [Abstract][Full Text] [Related]
18. Megestrol acetate for treatment of endometriosis.
Schlaff WD; Dugoff L; Damewood MD; Rock JA
Obstet Gynecol; 1990 Apr; 75(4):646-8. PubMed ID: 2314784
[TBL] [Abstract][Full Text] [Related]
19. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
[TBL] [Abstract][Full Text] [Related]
20. Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results.
Guarnieri A; Tucci E; D'Aniello C; Carli A; Mariani L; De Stefano A; Nardi P
Chemioterapia; 1984 Oct; 3(5):320-3. PubMed ID: 6241848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
